Download Title page - Stockholm Network

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Slovenian healthcare reform and the
prospects for innovation - an
“outsider's perspective
Dr Meir Pugatch, 15 Nov 2008
Fundamentals of Innovation in Health
• Concerns both products and services
• Relevant to the Macro level as much as it is to the Micro
level (i.e. National Innovation Strategies are also very
important)
• Generates greater value: physical, social and economic
• Rooted in market forces and incentives (Gov plays a role
but the market leads the way…)
• Long term benefits outweigh short term costs (though at
times immediate short terms benefits are also visible)
Healthcare Reforms in the CEE Region
• Dramatic change since 1989 – Post soviet era
• Healthcare reforms are part of sweeping and far reaching
changes (including flat taxes, reformed pension systems,
school vouchers, etc)
• Healthcare systems were transformed from a “command
and control style” (Semashko system) - owned by the
state, subject to central planning, and managed by similar
objectives and methods of operation – to a more pragmatic
“performance oriented” and open models.
• However, healthcare reforms in CEE countries are far
from complete and are still underway………
Common Challenges in CEE
• Medical institutions are still largely shielded from the need to
implement modern management techniques and improve
operational performance
• The provider side is still strongly concentrated and controlled
by the Gov, with a large emphasis on clinical centres and a
relative neglect of GP surgeries and other ways of providing
routine treatment for simpler cases
• Still a shortage of data on medical outcomes at the clinical
level. Such data is needed to properly evaluate providers’
performance and quality of service in general
• There is still some general hesitation (and at times resentment)
to further develop solutions that are based on public-private
partnerships (i.e. with the market)
Some Shared Objectives in CEE
• Search for a sustainable financing model
• Increasing access to medicines (sometimes this is
focused too much on controlling costs and increasing the
penetration of generics)
• Restructuring the role and relationship of different actors
in the health system
• Empowering patients
• Establishing competition between service providers
Healthcare Reform in Slovenia - Milestones
• 1889 - first Sick Fund is established in Ljubljana (emulating the
German model of social insurance - Bismarck model)
• 1918 - 1945 - establishment of a regional social hygiene
institute for prevention, primary care centres and a central
institute for hygiene and medicine
• 1945 - 1991 - gradual shift from the Social Insurance model to a
State owned and managed healthcare system. Universal
insurance is adopted (1974) and healthcare is provided via
regional centres (to our present day….)
• 1991 Slovenia becomes and independent state – and leads
significant reforms in Healthcare……
Some Key Milestones of Healthcare Reforms
• Introducing Compulsory health insurance (Law on Health Care and
Health Insurance 1992) – wide coverage of services
• Introduction of Voluntary (supplementary) health insurance (1993) By 2002 1.4 million people had taken out voluntary insurance (out of
total population of 2 million)
• Some decentralization of the health care system – also moving
towards the privatization of health care delivery ( private clinics of
physicians)
• New regulatory frameworks for medical technologies, including
pharmaceuticals (such as the Law on Medicinal Products and Medical
Devices adopted in 1999)
• As of 2000 greater focus on Improving quality and transparency and
evidence based measurements
Regulations of Pharmaceuticals – Zoom in
• Reference pricing system (85% of the average of a “basket” of
countries – Germany, France and Italy, 96% for innovative drugs)
• Health Insurance Institute (HII) responsible for the reimbursement of
drugs based on a “positive drug list” (fully reimbursed) “intermediate
drug list” (partially reimbursed) and “negative drug list” (mostly OTCs)
• Health Technology Assessment (HTA) for the purpose of evaluating the
economic value of a medicine is still nascent
• Increased tendency towards the monitoring of prescribing patterns and
practices of physicians
• Government would like to encourage the use of Generics (45% of the
market are branded generics)
• Direct to Consumer Information – not yet permitted
Implications on the Future of Innovation
Positive
• Greater tendency to work with the private sector in order
to create a financially sustainable healthcare model
(supplementary insurance, privatisation)
• Focus on transparency and quality assessment
• Shift towards evidence-based practices and effective
performance, including in the planning of health budgets
• Emphasis on capacity building and greater
professionalisation of the healthcare system
• More focus on patients’ needs and on long term goals
(prevention….)
Implications on the Future of Innovation
Negative
• Still a highly centralised system (not yet capitalising on
the advantages of decentralisation and privatisation)
• True competition between providers is still lacking (private
sector not fully utilised – hospitals, etc)
• Tendency towards cost containment of prices and
preference towards generics can deter the creation of a
stronger pharmaceutical R&D base
• Operational management of the healthcare system at all
levels still remain a challenge (though it has improved, such
as via a training programme for non-clinical managers was
launched in 2002)
Healthcare Reform - future focus…
 Creating a unified hospital system in Slovenia;
 Determination of the public health interest and proposals for
healthcare priorities;
 Categorisation of hospitals;
 Allocation of tasks between the public and private healthcare sectors
on the basis of concessions;
 Organisational standards for staff working in public healthcare
institutions;
 Development of a system of healthcare financing that focuses on
healthcare insurance holders;
 Allocation of resources between levels;
 budget guidelines;
 Investments in public healthcare institutions
 Indicators of efficiency and success of the healthcare system, healthcare
institutions and management;
 Provision of uniform complaints procedures within the healthcare
system, including the institute of a human rights ombudsman for the
healthcare system.
Health
Government
Expenditure (% of share (% of total
GDP)
health
expenditure)
Composition of
private spending
(Out-of-pocket to
voluntary
insurance)
Composition of
public spending
(social insurance
to tax funding )
Czech
Republic
7.1
89
98 : 02
90 : 10
Hungary
7.8
71
96 : 04
90 : 10
Poland
6.2
69
98 : 02
84 : 16
Romania
5.5
70
86 : 14
82 : 18
Slovenia
8.5
72
53 : 47
93 : 07
Source WHO Statistics (2008), SN 2008